Andrew Sunol

Andrew Sunol is an associate in Goodwin’s Private Equity group in New York. He represents large and middle-market private equity sponsors (and their portfolio companies) in a broad range of corporate transactions, including control and structured investments, leveraged buyouts, add-ons, industry roll-ups, convertible instruments, carve-outs, co-investments, divestments and exit transactions.

Andrew has also advised clients on take-private transactions, debt and equity financings, cross-border investments, founder capital and structuring matters, restructurings and reorganizations, distressed sales (including as part of Chapter 11 proceedings), as well as general corporate, shareholder, and governance matters.

Select representative matters include:

• Dun & Bradstreet in its pending $7.7 billion take-private sale to Clearlake Capital Group*
• Ontario Teachers Pension Fund on an employee stock repurchase for one of its portfolio companies*
• American Securities in its:
  • acquisition of assets from the Marjam Supply Company group, via its portfolio company Foundation Building Materials*
  • divestment of a significant stake in Foundation Building Materials to Clayton, Dubilier & Rice*
• Thomas H. Lee Partners (THL) in its majority controlling investment in Standish Management*
• Steward Health Care System LLC, the largest private, physician-owned for-profit healthcare network in the United States with over $9 billion in funded debt obligations, in connection with numerous time-sensitive hospital and asset sales as part of its Chapter 11 restructuring*
• Eli Lilly and Company on its acquisition of certain assets from Lacerta as a result of an assignment for the benefit of creditors proceeding*
• Funds associated with Mercury Capital on its roll-up of Australian recycling operators, including its:
  • lead co-investment in Australian recycling organization Re.Group*
  • acquisition of all business assets of Polytrade*
  • negotiation and closing of a pre-closing reorganization of Polytrade*
• Funds associated with Affinity Equity Partners on the ~$350 million sale of its portfolio company MedicalDirector to Telstra Health*
• Funds associated with PAG on its fully secured ~$150m investment into ASX-listed Regional Express Airlines via convertible notes during COVID-19*
• Founders of Skyline Landscaping on the competitive sale process and majority exit to a portfolio company controlled by Mercury Capital as part of Mercury's landscaping roll-up*
• Funds associated with Next Capital on its:
  • sale of Funlab, an Australian "leisure-tainment" business to funds associated with TPG Capital* for ~$250 million
  • co-investment into Eptec Group, a specialist defense and engineering contractor, and subsequent add-ons / related investments*

*Denotes experience prior to joining Goodwin.

Prior to joining Goodwin, Andrew worked as an associate in the New York office of Weil, Gotshal & Manges LLP where he advised large-cap sponsors, listed public companies and a range of private and distressed companies on a broad range of corporate transactions.

Before moving to the United States, Andrew worked as an associate in the Private Equity team of both Corrs Chambers Westgarth and MinterEllison in Sydney, Australia. Andrew has also previously served as an Officer in the Royal Australian Navy.

• New Colombo Plan Scholar